Lumanity Medical Affairs ConsultingUnclaimed
Host of Medical Affairs Unscripted.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
PodCred record
PodCred is the verified record of where Lumanity has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with Lumanity on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when Lumanity claims this profile.
Recommendations
No recommendations for Lumanity yet.
Recommendations open once Lumanity claims the profile.
Posts
No posts yet. Posts Lumanity shares on PodSubs, and what Lumanity publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Build or Inherit: Leading Biotech Medical Affairs from Clinical Trials to Commercialization
What happens when a biotech company waits too long to build the Medical Affairs capabilities it needs for a successful launch? Building a Medical Affairs organization is challenging. Transforming an existing team to...
Rethinking Global Medical Affairs: Co-Led Brand Strategy, Agile Teams & AI with Emad Siddiqui of Astellas
How can Medical Affairs teams move faster, align global brand strategy, and use artificial intelligence (AI) while keeping patients first? Emad Siddiqui, Senior Vice President, Head of Medical Affairs Global Brand...
One Size Does Not Fit All: Leading Medical Affairs Across a Diverse Portfolio
What happens when one Medical Affairs leader is responsible for oncology, neurology, immunology, fertility, HIV, and rare disease, all at the same time? The answer is not a bigger playbook. It is an entirely different...
Proactive vs. Reactive: How the SIUU Guidance is Reshaping Medical Affairs Strategy with Josh Bryson
The FDA finalized its guidance on Scientific Information on Unapproved Uses (SIUU) in January 2025, giving pharmaceutical and biotech companies a framework for proactive off-label communication with healthcare...
The Launch Starts Now: A CMO's Approach to Early Medical Affairs Strategy in Biotech with Nick Sarlis, MD, PhD, FACP
In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick speaks with Nick Sarlis, MD, PhD, FACP, Chief Medical Officer at Clara Biotech, about why successful biotech launches begin years before approval....
Medical Affairs as a Strategic Engine: De-Risking Biotech Development and Driving Commercial Success
What if the decisions that determine your drug's commercial success are already being made and medical affairs isn't in the room? In this episode of Medical Affairs Unscripted, Peg Crowley speaks with Nick Sen, SVP and...
Building the CMO Playbook: From Pre-IND to Launch in Early-Stage Biotech
In this episode, Peg Crowley-Nowick speaks with Joseph Elassal, MD, MBA, Chief Medical Officer of Ankyra Therapeutics, about the strategic, operational, and financial realities of leading clinical development from...
Medical Affairs Leadership: From Support Function to Strategic Lever
How Medical Affairs leaders can move their organizations from a supporting role to a strategic driver - through accountability, insight translation, and the smart use of AI. In this episode of Medical Affairs...
It Doesn't Take Months: How an Expert CMO Builds a TPP That Drives Success - With Jeff Humphrey, MD
Medical Affairs Unscripted welcomes Dr. Jeff Humphrey - an experienced CMO with three decades across Bristol Myers Squibb, Pfizer, Bayer, Kyowa Kirin, and multiple biotechs - to discuss why the Target Product Profile...
From First Patient Enrolled to First Script: Medical Affairs as the Throughline
Medical Affairs isn't a downstream function - it's the throughline connecting science, story, and strategy from development through commercialization. This episode features Howard Rutman, MD, MBA, Chief Medical Officer...
